日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  How can vaccine design be modified by the use of synthetic sugars?

Seeberger, P. H. (2017). How can vaccine design be modified by the use of synthetic sugars?. doi:10.21036/LTPUB10402.

Item is

基本情報

表示: 非表示:
資料種別: その他

ファイル

表示: ファイル

作成者

表示:
非表示:
 作成者:
Seeberger, Peter H.1, 著者           
所属:
1Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society, ou_1863308              

内容説明

表示:
非表示:
キーワード: -
 要旨: Streptococcus pneumoniae kills millions of people worldwide. For the subgroup serotype 8, prevalent in the United States and Western Europe, there is no vaccine to date. In this video, PETER H. SEEBERGER explains the approach of his research group to create a synthetic sugar vaccine against this bacterial infection that works in mice. They relied on synthetic chemistry to assemble sugar chains from monomers; the researchers then connected them to a carrier protein and tested whether they were immunogenic – causing an immune response in living organisms – and whether they were protective. Thus they succeeded in creating the vaccine. Their results have inspired further work in the area in the hope of finding a vaccine for humans. On a fundamental level, the researchers also found that the way in which sugars are presented to the immune system matters with respect to immunogenicity and protection. This has strong implications for future vaccine design.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2017-03-1720172017
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: -
 識別子(DOI, ISBNなど): DOI: 10.21036/LTPUB10402
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物

表示: